Prescription Justice
BLOG POSTS

31
Dec
2019
#
Prescription Justice is proud to announce that a statement prepared by PJ President Gabriel Levitt for the U.S. House Ways and Means Committee on “Investing In The U.S. Health System By Lowering Drug Prices, Reducing, Out-of-Pocket Costs and Improving the Medicare Benefit” is now part of the official congressional record.
Read More
23
Dec
2019
#
The New York Daily News recently published the Op-Ed United we stand, at least on drug prices by Prescription Justice President, Gabriel Levitt. Mr. Levitt’s Op-Ed underscores the fact that while there is little consensus among voters from different political parties, there is one stark exception: prescription drug prices.
Read More
24
Sep
2019
#
Elizabeth, who is from California, periodically gets migraine headaches. To treat them, she is prescribed brand name Relpax (elitriptan), but finds that the drug is too expensive in the U.S., so she chooses to import the same drug at a much lower price. Despite federal restrictions, most medicines that are imported for personal use reach the patient. But not always. In Elizabeth’s case, instead of receiving her medication, the Food and Drug Administration (FDA) destroyed the medication after it was detained at an international mail facility (IMF). She gave Prescription Justice the green light to tell her story.
Read More
03
Jul
2019
#
Founder of Prescription Justice, Gabriel Levitt, submitted a public comment to the World Health Organization (WHO) on the role of personal importation and online access to safe and affordable medicine in meeting the UN Sustainable Development Goals. The Global Action Plan for Healthy Lives and Well-Being for All is a joint initiative led by twelve global health and development organizations under the auspices of the WHO.
Read More
04
Apr
2019
#
Earlier this week, Prescription Justice founder Gabriel Levitt published an article in The Nation entitled, “Is the FDA Misleading Congress About the Safety of Imported Medicines?”. While we advocate for policies and legislative reforms to bring down drug prices here in the U.S., the article highlights the fact that personal prescription drug importation is already a lifeline for millions of Americans who can’t afford their medications here.
Read More

Stay informed about news and advocacy centered on the crisis of high drug prices